Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality

✍ Scribed by Hironori Harada; Mitsumasa Watanabe; Kenshi Suzuki; Soshi Yanagita; Takahiro Suzuki; Yataro Yoshida; Akiro Kimura; Mitsuru Tsudo; Akira Matsuda; Kaoru Tohyama; Masafumi Taniwaki; Kenichi Takeshita; Masaaki Takatoku; Keiya Ozawa

• Book ID: 107618852
• Publisher: Carden Jennings Publishing
• Year: 2009
• Tongue: English
• Weight: 228 KB
• Volume: 90
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1007/s12185-009-0400-8